✦ LIBER ✦

Systematic review: the safety and tolerability of pharmacological agents for treatment of irritable bowel syndrome – a European perspective

✍ Scribed by R. HEADING; K. BARDHAN; S. HOLLERBACH; A. LANAS; G. FISHER

Book ID: 108604576
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 210 KB
Volume: 24
Category: Article
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.2006.02937.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Systematic review: the efficacy of treat

Systematic review: the efficacy of treatments for irritable bowel syndrome – a European perspective

✍ J. TACK; M. FRIED; L. A. HOUGHTON; J. SPICAK; G. FISHER 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB

Systematic review: accuracy of symptom-b

Systematic review: accuracy of symptom-based criteria for diagnosis of irritable bowel syndrome in primary care

✍ P. JELLEMA; D. A. W. M. VAN DER WINDT; F. G. SCHELLEVIS; H. E. VAN DER HORST 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB

Review article: probiotics for the treat

Review article: probiotics for the treatment of irritable bowel syndrome – focus on lactic acid bacteria

✍ G. Clarke; J. F. Cryan; T. G. Dinan; E. M. Quigley 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

The use of novel promotility and prosecr

The use of novel promotility and prosecretory agents for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation

✍ Jeremy D. Gale 📂 Article 📅 2009 🏛 Springer Healthcare Communications 🌐 English ⚖ 217 KB

The efficacy, safety, and tolerability o

The efficacy, safety, and tolerability of donepezil for the treatment of young adults with Down syndrome

✍ Priya S. Kishnani; Barbara R. Sommer; Benjamin L. Handen; Benjamin Seltzer; Geor 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB 👁 2 views

## Abstract The objective of our study was to assess the efficacy and safety of donepezil in young adults with Down syndrome (DS) but no evidence of Alzheimer disease (AD). A 12‐week, randomized, double‐blind, placebo‐controlled study with a 12‐week, open‐label extension was conducted. The interven

Biofeedback treatment for headaches, Ray

Biofeedback treatment for headaches, Raynaud's disease, essential hypertension, and irritable bowel syndrome: A review of the long-term follow-up literature

✍ Ford, Martin R. 📂 Article 📅 1982 🏛 Springer-Verlag ⚖ 950 KB